Affinity Asset Advisors, LLC Centessa Pharmaceuticals PLC Transaction History

Affinity Asset Advisors, LLC

$560 Million
Q4 2024

A detailed history of Affinity Asset Advisors, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,095,924 shares of CNTA stock, worth $19.3 Million. This represents 3.28% of its overall portfolio holdings.

Number of Shares

1,095,924

Previous 965,612 13.5%

Holding current value

$19.3 Million

Previous $15.4 Million 18.89%

% of portfolio

3.28%

Previous 2.67%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$15.04 - $18.67 $1.96 Million - $2.43 Million	130,312 Added 13.5%	1,095,924 $18.4 Million
Q3 2024 Nov 13, 2024	SELL	$8.58 - $16.99 $1.46 Million - $2.89 Million	-170,090 Reduced 14.98%	965,612 $15.4 Million
Q2 2024 Aug 14, 2024	BUY	$8.04 - $11.87 $2.45 Million - $3.62 Million	305,156 Added 36.74%	1,135,702 $10.3 Million
Q1 2024 May 14, 2024	BUY	$6.73 - $12.2 $234,318 - $424,767	34,817 Added 4.38%	830,546 $9.39 Million
Q4 2023 Feb 13, 2024	SELL	$5.52 - $8.03 $1.23 Million - $1.79 Million	-222,362 Reduced 21.84%	795,729 $6.33 Million
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.24 $705,381 - $967,112	117,368 Added 13.03%	1,018,091 $6.59 Million
Q2 2023 Aug 14, 2023	BUY	$3.68 - $6.9 $797,073 - $1.49 Million	216,596 Added 31.66%	900,723 $5.58 Million
Q1 2023 May 15, 2023	BUY	$3.03 - $4.0 $678,110 - $895,196	223,799 Added 48.62%	684,127 $2.63 Million
Q4 2022 Feb 13, 2023	BUY	$3.05 - $4.19 $664,323 - $912,628	217,811 Added 89.81%	460,328 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$3.8 - $5.91 $921,564 - $1.43 Million	242,517 New	242,517 $975,000
Q2 2022 Aug 12, 2022	SELL	$3.18 - $9.85 $207,596 - $643,027	-65,282 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.45 - $11.59 $2.64 Million - $4.1 Million	-353,862 Reduced 84.42%	65,282 $586,000
Q4 2021 Feb 11, 2022	BUY	$10.99 - $17.54 $2.37 Million - $3.79 Million	215,961 Added 106.29%	419,144 $4.72 Million
Q3 2021 Nov 12, 2021	BUY	$16.7 - $23.11 $2.27 Million - $3.15 Million	136,226 Added 203.45%	203,183 $3.39 Million
Q2 2021 Aug 13, 2021	BUY	$21.71 - $25.66 $1.45 Million - $1.72 Million	66,957 New	66,957 $1.49 Million

Others Institutions Holding CNTA

# of Institutions

107

Shares Held

119M

Call Options Held

5.9K

Put Options Held

53K

View Full List

About Centessa Pharmaceuticals plc

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.66B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

More about CNTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Account

Affinity Asset Advisors, LLC Centessa Pharmaceuticals PLC Transaction History